Press release
Connected Oral Inhalers Latest Attempt to Improve Patient Self-Administration of Upper Respiratory Drugs
(Amherst, NH) – Upper respiratory tract (URT) conditions including asthma and chronic obstructive pulmonary disease (COPD) continue to be a health segment that presents challenges to the caregiver community. Patient adherence with prescribing instructions and treatment protocols remains sub-optimal across all patient categories, but particularly for the young and the elderly. This has led to significant interest on the part of device and product providers toward the development of connected inhalers. These inhalers incorporate features and design elements that address patient dosing errors and treatment adherence, in the process improving patient safety.The initial emphasis on connected oral inhalers has focused on add-on, or aftermarket, devices that are designed to wrap around the inhaler or be used as a ‘cap’ that allows the sensor(s) in the connection device to recognize when the device has been actuated. The connection device captures this information and sends it off-board to another device – typically a smartphone for relay to a data processing hub, from which patients and caregivers can access the data.
While the initial focus has been on adapting existing devices, the next generation will consist of oral inhalers with connectivity integrated into the inhaler device design. Key players in this segment include Novartis and Boehringer Ingelheim (BI), in collaboration with Qualcomm, and Aptar which is working with Propeller Health. Two major drug inhalation developers – AstraZeneca and BI - are pursuing multiple development paths by partnering with more than one technology supplier.
The market for connected inhalers is changing rapidly, with new collaborations being announced every couple of months and at least one add-on device supplier diversifying into the next-gen device integration space. Other important players in this market include Glaxo, 3M, Vectura, Gecko (now a part of Teva Respiratory), Adherium, and Cohero.
A comprehensive analysis of connected inhalers and their growing impact on respiratory therapeutic markets is included in a new and comprehensive report. The report, Connected Oral Inhalers, includes assessments of inhaler connection devices and connected inhalers, analysis of the impact of connected inhalers on URT therapeutic markets, market data and forecasts and profiles of market participants.
More information is available at
http://www.greystoneassociates.org
Source: Greystone Research Associate
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Connected Oral Inhalers Latest Attempt to Improve Patient Self-Administration of Upper Respiratory Drugs here
News-ID: 373854 • Views: …
More Releases from Greystone Research Associates
Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration…
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors.
A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when…
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population.
To fully address the unmet need these technologies…
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from…
More Releases for Associate
JJC Law Welcomes Associate Attorney Grant Wood
New Orleans, LA – Louisiana’s JJC Law is delighted to announce the addition of Grant Wood to its highly regarded legal team.
Wood will help maintain the boutique law firm’s commitment to excellence by representing its clients primarily in the areas of motor vehicle accidents, premises liability, maritime and general personal injury.
JJC Law specializes in handling personal injury claims, claims against insurance companies (such as property/hurricane claims), and…
Alliance India crosses 1000 associate mark
Hyderabad: Alliance Global Services, the fastest growing provider of software design, development, and quality management services, announced on Tuesday that it has crossed the 1000 associate mark at its offshore delivery facility in Hyderabad, India. This significant growth milestone comes on the heels of new client acquisitions and engagements in the first quarter of 2015.
“We were less than 300 associates in India when we launched Alliance Global Services…
Brady Associate Receives National Standards Certification
GREENSBORO N.C. (June 29, 2011) — Brady (bradyservices.com), a company that provides high-efficiency HVAC systems and comprehensive building solutions for commercial and industrial facilities across North Carolina, announces today that Brian Smith has received Level II Analyst Certification by the Vibration Institute (vibration.org). The certification program is accredited by the American National Standards Institute.
Vibration analysis is an important part of maintaining peak performance for equipment that includes rotating parts. It…
New Associate Joins Williams Venker & Sanders
ST. LOUIS, MO – April 7, 2009 – Williams Venker & Sanders LLC is pleased to announce the addition of its newest associate, Matthew E. Pelikan (mpelikan@wvslaw.com). Matthew brings with him a strong background in litigation, specifically in the areas of toxic torts, labor and employment, worker’s compensation, products and premises liability and general commercial issues. He has handled every aspect of case management from acknowledgement through resolution,…
Fish & Richardson Adds Patent Prosecution Associate
AUSTIN, Texas – The national law firm of Fish & Richardson, P.C., is announcing the addition of Josh Tucker as an associate in the firm’s patent prosecution group.
Mr. Tucker joins the Austin office after serving as an associate at Houston’s Fletcher Yoder for the past three years, where he helped draft and prosecute patent applications.
He graduated with honors from the University of Texas School of Law in 2004,…
Fish & Richardson P.C. Adds New Associate
AUSTIN, Texas – The national law firm of Fish & Richardson, P.C., is announcing the addition of Chris R. Johnson as an associate in the firm’s litigation group.
Before joining Fish & Richardson, Mr. Johnson worked as a law clerk to the Hon. Alvin A. Schall of the United States Court of Appeals for the Federal Circuit. Mr. Johnson earned his law degree from Duke University in 2006, graduating magna cum…
